Registration
THE KPM GROUP DC LLC for SANGAMO THERAPEUTICS, INC
Firm
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, STAT Act Cures 2.0 (not introduced) PDUFA VII Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE LANDES New | — |
| PATROSKI LAWSON New | — |
| BENJAMIN MASON New | Communications Director, Rep. David Young January 2017 - June 2017 |
Pharmacy PHA
Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, STAT Act Cures 2.0 (not introduced) PDUFA VII Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE LANDES New | — |
| PATROSKI LAWSON New | — |
| BENJAMIN MASON New | Communications Director, Rep. David Young January 2017 - June 2017 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.